| scholarly article | Q13442814 |
| P50 | author | Richard W Titball | Q87944728 |
| D Huw Davies | Q88368580 | ||
| Philip L. Felgner | Q90974131 | ||
| Direk Limmathurotsakul | Q28321770 | ||
| Ganjana Lertmemongkolchai | Q39049736 | ||
| P2093 | author name string | Gregory J Bancroft | |
| Duangchan Suwannasaen | |||
| Jirawan Mahawantung | |||
| Wipada Chaowagul | |||
| P2860 | cites work | Melioidosis: epidemiology, pathophysiology, and management | Q24522461 |
| Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II | Q24556834 | ||
| Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei | Q24564168 | ||
| Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei | Q33427795 | ||
| Immunogenic Burkholderia pseudomallei outer membrane proteins as potential candidate vaccine targets | Q33490609 | ||
| Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery | Q33756925 | ||
| Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei | Q33877205 | ||
| Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature | Q33922796 | ||
| Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. | Q33987410 | ||
| Alkyl hydroperoxide reductases C and D are major antigens constitutively expressed by Mycobacterium avium subsp. paratuberculosis | Q34003312 | ||
| Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. | Q34034124 | ||
| Profiling humoral immune responses to P. falciparum infection with protein microarrays | Q34495128 | ||
| Risk factors for recurrent melioidosis in northeast Thailand | Q34567077 | ||
| Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice | Q34601672 | ||
| Protein microarrays: from serodiagnosis to whole proteome scale analysis of the immune response against pathogenic microorganisms. | Q35039593 | ||
| Recent development in melioidosis. | Q35691091 | ||
| Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis | Q35949725 | ||
| Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax | Q36424513 | ||
| Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine | Q36498147 | ||
| A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens | Q37278865 | ||
| Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection | Q39045754 | ||
| Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens | Q39171860 | ||
| An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling. | Q39764626 | ||
| Serological Diagnosis of Human Melioidosis with Indirect Hemagglutination and Complement Fixation Tests | Q40714576 | ||
| From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis | Q46315736 | ||
| Immunodominant Francisella tularensis antigens identified using proteome microarray. | Q51579914 | ||
| Profiling the humoral immune response to Borrelia burgdorferi infection with protein microarrays | Q79768881 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Burkholderia pseudomallei | Q140475 |
| P304 | page(s) | 1002-1011 | |
| P577 | publication date | 2011-02-07 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Human immune responses to Burkholderia pseudomallei characterized by protein microarray analysis | |
| P478 | volume | 203 |
| Q36133960 | A Pneumococcal Protein Array as a Platform to Discover Serodiagnostic Antigens Against Infection. |
| Q40672654 | A targeted immunomic approach identifies diagnostic antigens in the human pathogen Babesia microti. |
| Q40085222 | Anti-Cancer Drug HMBA Acts as an Adjuvant during Intracellular Bacterial Infections by Inducing Type I IFN through STING. |
| Q37910754 | Autotransporters and Their Role in the Virulence of Burkholderia pseudomallei and Burkholderia mallei |
| Q38773109 | Boosting of post-exposure human T-cell and B-cell recall responses in vivo by Burkholderia pseudomallei-related proteins |
| Q39197155 | Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials? |
| Q39284204 | CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis |
| Q35834729 | Characterization of the murine macrophage response to infection with virulent and avirulent Burkholderia species. |
| Q30417055 | Distinct human antibody response to the biological warfare agent Burkholderia mallei. |
| Q27697853 | From crystal structure to in silico epitope discovery in the Burkholderia pseudomallei flagellar hook-associated protein FlgK |
| Q37035962 | Functional characterization of Burkholderia pseudomallei trimeric autotransporters |
| Q54242408 | Immune Control of Burkholderia pseudomallei--Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes. |
| Q55283697 | Immune response to recombinant Burkholderia pseudomallei FliC. |
| Q38937699 | Immunisation with proteins expressed during chronic murine melioidosis provides enhanced protection against disease |
| Q36676050 | Immunoproteomics: the key to discovery of new vaccine antigens against bacterial respiratory infections. |
| Q33597011 | Increased Neurotropic Threat from Burkholderia pseudomallei Strains with a B. mallei-like Variation in the bimA Motility Gene, Australia |
| Q39129977 | Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomallei |
| Q36363475 | Leptospiral outer membrane protein microarray, a novel approach to identification of host ligand-binding proteins |
| Q48144660 | Melioidosis: where do we stand in the development of an effective vaccine? |
| Q26800283 | New approaches to understanding the immune response to vaccination and infection |
| Q34783879 | Novel Burkholderia mallei virulence factors linked to specific host-pathogen protein interactions. |
| Q59599346 | Postgenomic Approaches and Bioinformatics Tools to Advance the Development of Vaccines against Bacteria of the Complex |
| Q39407784 | Quantitative proteomic analysis of Burkholderia pseudomallei Bsa type III secretion system effectors using hypersecreting mutants |
| Q36079942 | Rapid and Sensitive Multiplex Detection of Burkholderia pseudomallei-Specific Antibodies in Melioidosis Patients Based on a Protein Microarray Approach. |
| Q30279061 | Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders |
| Q27702559 | Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063 |
| Q35723661 | Sequence- and Structure-Based Immunoreactive Epitope Discovery for Burkholderia pseudomallei Flagellin |
| Q40048191 | The Use of Reverse Vaccinology in the Design and Construction of Nano-glycoconjugate Vaccines against Burkholderia pseudomallei |
| Q34275632 | The impact of "omic" and imaging technologies on assessing the host immune response to biodefence agents |
Search more.